Please enable javascript in your web browser in order to use EASD OnDemand at its best.
Please enable cookies in your web browser to be able to log in.
You are using an outdated web browser EASD OnDemand possibly do not work with properly. Please update your web browser.
More information
Browse
Type in a keyword to specify your content
Browse
Hide Filter Settings
Event
All Events
Lisbon 2011 (218)
Stockholm 2010 (197)
Vienna 2009 (57)
Rome 2008 (68)
Group
All Groups
EASD Scientific Programme (540)
Session
All Sessions
"Clock genes" and diabetes (1)
"The metabolic brain" (1)
23rd Camillo Golgi Lecture (1)
24th Camillo Golgi Lecture (1)
25th Camillo Golgi Lecture (1)
26th Camillo Golgi Lecture (1)
42nd Claude Bernard Lecture (1)
43rd Claude Bernard Lecture (1)
45th Minkowski Prize Lecture (1)
46th Minkowski Lecture (1)
4th Albert Renold Lecture (1)
Adipose tissue at the crossroad of the "metabolic syndrome" (3)
Advances in genetics: where are they leading us? (1)
Announcement of EFSD activities and Induction of Honorary Members (1)
Announcement of EFSD activities and Induction of Honorary Members (1)
Announcement of new EFSD activities and induction of Honorary Members (1)
Apple and pear: implications of fat distribution on the development of type 2 diabetes (1)
Are genes making us sick? (2)
Assessing beta cell function in humans: Old and novel paradigms (2)
Balloon Debate Symposium: Step 2 of the EASD/ADA therapeutic algorithm: Are all drugs equal? (3)
Bariatric surgery - a cure for type 2 diabetes (3)
Beta cell - metabolic coupling and amplifying pathways (3)
Beta cell imaging (2)
Cardiovascular disease: glucose matters? (2)
Clinical beta cell replacement: what's new? (1)
Clinical management of obesity (3)
Closing Ceremony (1)
Closing Ceremony (3)
Complex diseases: How to proceed after a genome-wide association study? (3)
Controversies in dietary strategies in the treatment of diabetes (3)
Controversies in gestational diabetes (2)
Debate on continuous glucose monitoring (1)
DESG-EASD Symposium: Tools to achieve goals - therapeutic patient education (4)
DFSG-EASD Symposium: Update on the diabetic foot (2)
Diabetes and cancer related mechanisms (3)
Diabetes and neuro-degeneration: lessons from neurology (2)
Diabetes and the bone (3)
Diabetes and the lung (2)
Diabetes Care in Europe: striving for excellence (2)
Diabetes in the context of psychiatric illness (2)
Diabetes in young people (1)
Diabetes therapy and cancer (4)
Diabetes, obesity and cancer (4)
Diabetes: similarities and differences between East and West (2)
Diabetic foot treatment - getting off on the right foot and keeping it on the ground (2)
DIAMAP Report on European Commission FP7 Road Map for European Diabetes Research (1)
Do GLP-1 based therapies increase cancer risk? (1)
DPSG-EASD Symposium: Metabolic programming - a prenatal concern (2)
Driving and diabetes: Risks and responsibilities (2)
EASD/ADA Symposium in memoriam Dennis McGarry: What if Minkowski had been ageusic? (1)
EASD/ADA Symposium: Diabetes and pregnancy: determinants of neonatal and maternal complications (3)
EASD/ADA Symposium: Obesity and type 2 diabetes: What's similar and what's different? (3)
EASD/ADA Symposium: Provisonal WHO new diagnostic criteria 2010 (2)
EASD/ESC Symposium: Diabetes risk with cardioprotective therapies: what are they and do they matter? (2)
EASD/ESC Symposium: News on diabetic cardiomyopathy (1)
EASD/ESC Symposium: The metabolic interface between diabetes and the failing heart (3)
EASD/ESC Symposium: Vascular actions of insulin (3)
EASD/ISPAD Symposium: Genotyping and phenotyping in type 1 diabetes: Relevance for disease pathogenesis and preventive therapy (3)
EASD/ISPAD Symposium: The European SWEET-project: addressing the heterogeneity of paediatric diabetes care (2)
EASD/JDRF Symposium: Artificial pancreas technologies - progress towards a mechanical closed-loop system to restore euglycaemia (4)
EASD/JDRF Symposium: Beta cell neogenesis: New hopes from stem cells? (1)
EASD/JDRF Symposium: New approaches in islet biology (2)
Endoplasmatic Reticulum (ER) stress in type 2 diabetes (3)
Endoplasmic Reticulum Stress: a novel mechanism in diabetes and diabetic complications (2)
Exercise in type 2 diabetes (3)
Foetal programming (1)
From genetic association to molecular mechanism and pathophysiology (3)
Galileo Lecture (1)
Geoethnic evolution of type 2 diabetes (2)
Glucose control in the hospital (1)
Gut microbiota: fighting diabetes from within? (1)
Hyperglycaemic tissue damage (3)
Hypoxia in diabetes: friend or foe? (2)
Inflammation in adipose tissue and type 2 diabetes (3)
Inflammation: a link between vascular and metabolic functions (1)
Islet microenvironment (2)
Late breaking GWAS - can we handle the data? (1)
Late breaking news from clinical trials (2)
Lipid-lowering strategies and diabetes: are all issues solved? (2)
Liver fat and diabetes, new insights and clinical relevance (2)
Mechanisms in autoimmune diabetes: lessons from other autoimmune diseases (2)
Mechanisms of beta cell degeneration - ROS and metabolic stress (3)
Meeting the challenges of diabetes and depression (2)
Melatonin - Good morning to an unexpected culprit in type 2 diabetes (3)
Metabolic pathways and coupling in insulin secretion (3)
Michael Berger Debate: HbA1c - where to set the target? (2)
Michael Berger debate: Is diabetic autonomic neuropathy a reversible diabetic complication? (2)
Michael Berger debate: Is it all about the blockade of the renin (2)
Michael Berger Debate: Much ado about postprandial glucose? (1)
Michael Berger Evidence-based medicine debates (2)
NEURODIAB-EASD Symposium: Diabetic neuropathy - new insights into an old problem (4)
New insights in insulin signalling (2)
New insights into dysfunction of Langerhans islets (1)
New Onset Diabetes After Transplantation (NODAT) (3)
Non-insulin antidiabetic agents - typical and atypical effects (1)
Novel insight into oxidant stress and long-term diabetic complications (2)
Novel roads in the assessment and management of diabetic neuropathy (2)
Novel therapeutic strategies for targeting insulin resistance and systemic inflammation (2)
OP 01 Assessing cardiovascular risk (5)
OP 01 Novel formulations and delivery of insulin (3)
OP 02 Diabetic foot and acute osteoarthropathy (3)
OP 02 Screening and prevention of gestational diabetes (2)
OP 03 Cardiovascular disease in type 1 diabetes (1)
OP 03 Nutrition and diet (4)
OP 04 Brown adipose tissue and mitochondria (4)
OP 04 Gastrointestinal factors and insulin secretion (3)
OP 05 Genetics of type 1 diabetes (5)
OP 05 Somatic and autonomic neuropathy (1)
OP 06 Ethnic and psychosocial disparities in diabetes (1)
OP 06 Insulin secretion and exocytosis (4)
OP 07 Nephropathy: epidemiology and clinical trials (3)
OP 07 The effects of insulin beyond glycaemia (1)
OP 08 Continuous glucose monitoring - a promise of improvement? (5)
OP 08 Stem cells and regeneration (5)
OP 09 GWAS and their follow-up: analytical, technological and experimental developments (1)
OP 09 Prediction of complications in type 2 diabetes (6)
OP 10 Exploring mechanisms of insulin resistance (2)
OP 10 Lipids in and out of context (2)
OP 11 Education (4)
OP 12 Metabolic control of beta cells (3)
OP 12 Vascular actions, new and established therapies (5)
OP 13 GLP-1 receptor agonists (2)
OP 13 Incretin based therapies: new developments (2)
OP 14 Diabetes in childhood (4)
OP 15 Gestational diabetes mellitus (3)
OP 15 Manipulating the gut to treat metabolism (2)
OP 16 Mechanisms of insulin secretion (1)
OP 16 Nephropathy: experimental (4)
OP 17 GWAS and next generation sequencing (2)
OP 17 Role of mitochondria in muscle insulin action (1)
OP 18 Diabetic nephropathy - experimental (1)
OP 18 Signal transduction (2)
OP 19 Insulin therapy (5)
OP 19 Large studies - new data (5)
OP 20 Diabetic foot - mechanisms and treatment (4)
OP 20 Regulation of hepatic glucose production (3)
OP 21 Intertissue crosstalk in metabolism (2)
OP 21 Novel cardiovascular biomarkers (3)
OP 22 Gastro-entero-pancreatic hormones (6)
OP 22 Making and replacing islet beta cells (4)
OP 23 Brain metabolism and food intake (2)
OP 23 Genes and islets (4)
OP 24 Beta cell damage (4)
OP 24 Childhood diabetes: What is new? (1)
OP 25 Diabetes morbidity and mortality (4)
OP 25 SGLT-2 inhibitors (2)
OP 26 Glycaemia and cardiovascular disease (4)
OP 26 Hypertension and retinopathy (2)
OP 27 Diagnosis and natural history of type 1 diabetes (2)
OP 27 Incretins: mechanistic studies (3)
OP 28 Genetics of type 2 diabetes (4)
OP 28 Targeting of beta cell genes in vivo (6)
OP 29 Adipose tissue inflammation (2)
OP 29 Type 1 diabetes mellitus genetics: expression, interaction and function (6)
OP 30 Insulin action and glucose uptake in vitro (3)
OP 30 Neuropathy: experimental and clinical (3)
OP 31 Metabolic effect of bariatric surgery (5)
OP 31 Prevention of type 2 diabetes mellitus (4)
OP 32 Hypertension and heart failure (3)
OP 32 Novel agents for type 2 diabetes (5)
OP 33 HbA1c for diabetes mellitus diagnosis: need for reassessment? (5)
OP 33 Immunology (4)
OP 34 Hypoxia and remodelling of adipose tissue (4)
OP 34 Inflammation in insulin resistance (1)
OP 35 Health care delivery (2)
OP 35 Novel aspects of beta cell function (5)
OP 36 Adipose tissue biology and inflammation (4)
OP 36 Psychological aspects (4)
OP 37 Diabetes and cancer (2)
OP 37 Type 1 diabetes mellitus: incidence, natural history, morbidity and mortality (2)
OP 38 Adiposity and cardiovascular disease (2)
OP 39 CNS, appetite control and cognition (3)
OP 39 Prediction of type 2 diabetes (2)
OP 40 The diabetic patient in the hospital (2)
OP 40 Transplantation (3)
OP 41 Deregulation of fatty acid handling, obesity and diabetes (3)
OP 41 Retinopathy: experimental (2)
OP 42 Inflammation and metabolism (3)
OP 42 Postprandial metabolism (4)
OP 43 DPP-4 inhibitors (1)
OP 43 New oral agents (2)
OP 44 Impact of education on glycaemic outcome (3)
OP 44 Nonalcoholic fatty liver disease (3)
OP 45 Brain effects on weight regulation and metabolism (3)
OP 45 Hypoglycaemia (2)
OP 46 Islet electrophysiology (2)
OP 46 Prediction of type 2 diabetes: Can we do better than the usual suspects? (3)
OP 47 Proteomics in diabetes (4)
OP 47 Socio-economic aspects (3)
OP 48 Biomarkers of type 1 diabetes (1)
OP 48 Devices (2)
Opening Ceremony (2)
Opening Ceremony (1)
Opening Ceremony (3)
Opening Ceremony (2)
Oral antidiabetic agents - recent endpoint trials (2)
Oral antidiabetic agents 2009 (2)
Presidential Address (1)
Protective mechanisms in type 1 diabetes (1)
Proteomics in clinical diabetes (4)
Regulation of energy metabolism (3)
Renal disease and diabetes: the plague of today (2)
Rising Star Symposium (2)
Rising Star Symposium (4)
Rising Star Symposium (3)
Rising Star Symposium (2)
Role of the CNS in diabetes (3)
Sex matters (3)
Stem cells and related approaches (1)
The future of antidiabetic drug development (2)
Towards applied genetics (2)
Type 1 diabetes genetics - status and future (1)
Type 2 diabetes and obesity in childhood (2)
UKPDS 30 year data - are there legacy effects of improved glucose and blood pressure control? / Veterans Affairs Diabetes Trial (4)
UN Summit on non-communicable diseases and Presidential Address (2)
Upcoming paradigms in metabolic disease (3)
Vesicle trafficking in diabetes - new aspects of a dynamic story (3)
← Previous
1
2
3
4
5
6
7
8
9
…
44
45
Next →
Title:
Opening Ceremony 1
Session:
Opening Ceremony
Author:
Smith, Ulf
Presented at:
Lisbon 2011
Title:
Opening Ceremony 2
Session:
Opening Ceremony
Author:
Gardete-Correia, Luís
Presented at:
Lisbon 2011
Title:
President, IDF, Cameroon: UN Summit on non-communicable diseases
Session:
UN Summit on non-communicable diseases and Presidential Address
Author:
Mbanya, Jean-Claude
Presented at:
Lisbon 2011
Title:
President, EASD and EFSD, Sweden: Presidential Address
Session:
UN Summit on non-communicable diseases and Presidential Address
Author:
Smith, Ulf
Presented at:
Lisbon 2011
Title:
Exploiting biomarkers and large datasets for insights into diabetes and cardiovascular disease
Session:
46th Minkowski Lecture
Author:
Sattar, Naveed
Presented at:
Lisbon 2011
Title:
An examination of multiple cardiovascular endpoints in individuals with screen-detected type 2 diabetes in the ADDITION-Europe trial: intervention effects and methodological insights
Session:
OP 01 Assessing cardiovascular risk
Author:
Simmons, Rebecca
Presented at:
Lisbon 2011
Title:
Comparison of ACCORD trial outcomes with outcomes estimated from modelled and meta-analysis studies
Session:
OP 01 Assessing cardiovascular risk
Author:
Foos, Volker
Presented at:
Lisbon 2011
Title:
An improved model to estimate lifetime health outcomes of patients with type 2 diabetes using 30-year follow-up data from the United Kingdom prospective diabetes study
Session:
OP 01 Assessing cardiovascular risk
Author:
Hayes, Alison
Presented at:
Lisbon 2011
Title:
Calculating risk in patients with type 2 diabetes in The Netherlands: UKPDS versus ZODIAC risk engine performance (ZODIAC-26)
Session:
OP 01 Assessing cardiovascular risk
Author:
Kleefstra, Nanne
Presented at:
Lisbon 2011
Title:
Health-related quality of life predicts survival in patients with type 2 diabetes and myocardial infarction: a report from the DIGAMI2 trial
Session:
OP 01 Assessing cardiovascular risk
Author:
Kjellstrom, Barbro
Presented at:
Lisbon 2011
Title:
Pilot study: activity of brown adipose tissue in healthy men during fasting and feeding
Session:
OP 04 Brown adipose tissue and mitochondria
Author:
Vrieze, Anne
Presented at:
Lisbon 2011
Title:
Expression of brown adipose tissue markers in different human adipose tissue depots
Session:
OP 04 Brown adipose tissue and mitochondria
Author:
Cheung, Louisa
Presented at:
Lisbon 2011
← Previous
1
2
3
4
5
6
7
8
9
…
44
45
Next →
